Increased hospital spending at high-cost hospitals does not appear to be associated with better short-term survival rates for patients with sepsis, according to a report in the February 28 issue of Archives of Internal Medicine.
"Sepsis affects approximately 750,000 patients each year in the United States and is in many ways a model condition for examining the relationship between hospital spending and patient outcomes and for identifying potential opportunities to improve the value of hospital care," the authors write as background information in the article.
Tara Lagu, MD, MPH, of the Baystate Medical Center in Springfield, Mass., and of Tufts University School of Medicine in Boston, and colleagues conducted a cross-sectional study of hospitals to determine whether higher levels of hospital spending were associated with better survival rates for patients with sepsis. Using the Perspective database, data were collected on 309 hospitals that cared for at least 100 patients with sepsis between June 1, 2004 and June 30, 2006.
The 309 hospitals contributed more than 166,900 patients during the study period. The average age of patients was 70 years, 52 percent were women and the majority (62 percent) were white. Of the hospitals included in the study, most (84 percent) were located in urban areas and half (49 percent) were in the southern United States.
Overall, 33,192 patients (20 percent) died while in the hospital. The median expected mortality (death) rate for all hospitals was 19.2 percent. Of the hospitals with expected mortality between 18.5 and 19.5 percent, observed mortality rates ranged from 9.2 to 32.3 percent. Overall, 66 hospitals (21 percent) had a clinically and statistically significant higher-than-expected mortality rate. Twenty hospitals had observed mortality rates between 10 percent and 25 percent above the expected rate and 46 hospitals exceeded predicted mortality by 25 percent.
The median unadjusted hospital average cost per case was $18,256. More than one-third (34 percent) of hospitals exceeded expected costs by at least 10 percent, with a median excess cost per case of $5,207. When examining costs and mortality simultaneously, 22 hospitals (7 percent) had both significantly lower-than-expected costs and mortality rates, and 30 hospitals (10 percent) had both higher-than-expected costs and mortality rates.
The authors also identified a subset of institutions that provided high-value and lower-value care. Twenty-two hospitals (7 percent) had both significantly lower-than-expected costs and mortality rates, while 105 hospitals had higher-than-expected costs. These findings highlight potential opportunities to improve the value of sepsis care. For example, the 63,833 study patients treated at the 105 hospitals with higher than expected mean costs represent a potential $332 million dollars in excess hospital spending (using the median of $5,207 above expected costs).
"Hospital spending and adjusted mortality rates for patients with sepsis vary substantially, but higher hospital expenditures are not associated with better survival," the authors conclude. "Efforts to enhance the value of sepsis care could be modeled on hospitals that achieve lower-than-expected mortality and costs."
Reference: Arch Intern Med. 2011;171[4]:292-299.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.